![](/img/cover-not-exists.png)
PCN50 COSTS OF TREATMENT WITH ANGIOGENESIS INHIBITORS (AIS) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RESULTS FROM A MEDICAL CHART REVIEW STUDY
WK Oh, DF McDermott, MS Duh, L Antràs, K Chen, SP Sarda, A Luka, S Whittemore, P Ramamurthy, MP Neary, TK ChoueiriVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72139-2
File:
PDF, 77 KB
english, 2010